Skip to main content
Science|Business

Bringing together industry, research and policy

Menu
  • News
    • Funding Newswire
    • The Widening
    • R&D Policy
    • Health
    • Energy
    • Climate
    • Digital
    • Defence
  • Funding Newswire
    • Why subscribe?
  • Reports
  • Events
  • The Network
    • Latest updates
    • Why Join?
    • Testimonials
    • Become a member
    • The Widening
    • Network news
  • Communications Services
    • Overview
    • Strategic advice
    • Campaigns
    • Events
    • Reports
    • Sponsorships
    • EU Projects
    • Enquire today
  • About Us
    • Contact
    • Team
    • Privacy
    • Careers
  • All
  • R&D Policy
    • Technology transfer
    • Horizon Europe
    • Start-ups
    • International news
    • Brexit
    • European Research Council
    • Universities
    • EU budget
    • Research and innovation gap
    • FP10
    • European Institute of Innovation and Technology
    • Intellectual property
    • Patents
    • European Research Area
    • European Innovation Council
    • Planning FP10
    • SMEs
    • Research infrastructures
    • Partnerships
    • Open science
    • Industry
    • Sovereignty
    • Missions
    • Cohesion policy
    • Basic science
    • Careers
    • Assessment
    • Erasmus
    • Synergies
  • Health
    • Life sciences
    • Drug development
    • COVID-19
    • Biotech
    • Vaccines
    • Clinical trials
    • Antimicrobial resistance
    • Medical technology
  • R&D Funding
  • Energy
    • Renewables
    • Hydrogen
    • Nuclear fusion
    • Batteries
    • Mobility
  • Digital
    • ICT
    • AI
    • Quantum computing
    • Semiconductors
    • Data
    • Super computers
    • Robotics
  • Climate
    • Green technology
    • Low-carbon
    • Circular economy
    • Agrifood
    • Biodiversity
    • Oceans
  • Defence
    • Dual use
    • European Defence Fund
    • Aerospace
    • Cybersecurity
    • European Space Agency
  • By Table.Media

Galapagos acquires UCL spin out in €12.5M all-share deal

Galapagos NV is bolstering its ability to select drug targets and compounds by acquiring Inpharmatica Ltd in an all-share transaction that values the UK bioinformatics company at €12.5 million.
12 Dec 2006
News

Glaxo pays £230M for preclinical portfolio of small antibodies

In the highest value deal yet seen for a preclinical pipeline, GlaxoSmithKline plc swooped on Domantis Ltd, paying £230 million cash for the six-year-old UK Medical Research Council spin out.
12 Dec 2006
News

Eindhoven: cleaning contaminated gas streams

11 Dec 2006
Energy

Delft: a new low-energy chemical process

11 Dec 2006
News

Another three bricks in the innovation wall

Three reports, two commissioned by possible next premier Gordon Brown and one inspired by him provide a glimpse of the future shape of UK innovation policy.
05 Dec 2006
News

Users prefer strong protection to patenting lite

Watertight protection is more important than the speed with which patents are granted, according to a survey of business and academia.
05 Dec 2006
News

Danish biotech upstages its nearest neighbour

Danish biotech is on the rise and has outpaced its closest neighbour, Sweden, according to a study published last week.
05 Dec 2006
News

Intellectual property, Russia and the MP3 site: an update

The notorious MP3 site AllofMP3.com is still functioning – despite the US–Russian agreement on intellectual property.
05 Dec 2006
News

Santhera teams up with Basel on treatments for rare neuromuscular devices

05 Dec 2006
News

PanGenetics licenses antibody from Schering-Plough in $50M deal

05 Dec 2006
News

Pagination

  • Previous page ‹‹
  • You're on Page 650
  • Next page ››

Get the Science|Business newsletters

newsletter iconReceive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening. 

  Sign up for the Funding Newswire

  Sign up for the Policy Bulletin

  Sign up for The Widening

Funding Newswire subscription

align-right

Follow where the public and private R&I money is going and which collaborative opportunities you can pursue. 

Subscribe today

Log in

Find out more about the Science|Business Network

Network iconA unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.

  Why join?

  Become a member

Jobs

FY2025 Call for RIKEN ECL Team/Unit Leaders
Home

Privacy   |   T&Cs   |   © 2025 Science Business Publishing Ltd.

  • News
    • Funding Newswire
    • The Widening
    • R&D Policy
    • Health
    • Energy
    • Climate
    • Digital
    • Defence
  • Funding Newswire
    • Why subscribe?
  • Reports
  • Events
  • The Network
    • Latest updates
    • Why Join?
    • Testimonials
    • Become a member
    • The Widening
    • Network news
  • Communications Services
    • Overview
    • Strategic advice
    • Campaigns
    • Events
    • Reports
    • Sponsorships
    • EU Projects
    • Enquire today
  • About Us
    • Contact
    • Team
    • Privacy
    • Careers